Related Experiment Video

Updated: Aug 15, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

[Down-regulation of CT120A by RNA interference suppresses lung cancer cells growth]

Dong-ning Pan1, Lin Wei, Ming Yao

  • 1National Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai 200032, China.

Zhonghua Yi Xue Za Zhi
|September 28, 2005
PubMed
Abstract

Insights

Down-regulating the CT120A gene using RNA interference significantly suppresses lung cancer cell growth and tumorigenicity. This finding suggests CT120A is a potential drug target for lung cancer treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Expression Analysis

Background:

  • Lung cancer remains a leading cause of cancer-related mortality worldwide.
  • Identifying novel therapeutic targets is crucial for improving patient outcomes.
  • CT120A, a novel human plasma membrane-associated gene, has been implicated in cellular processes.

Purpose of the Study:

  • To validate findings on CT120A.
  • To elucidate the role of CT120A in lung cancer cell proliferation.

Main Methods:

  • Utilized vector-based small hairpin RNA (shRNA) to target CT120A in human lung adenocarcinoma SPC-A-1 cells.
  • Assessed CT120A expression levels using RT-PCR and Western blotting.
  • Evaluated cell proliferation, soft agar colony formation, tumorigenicity in nude mice, and apoptosis via flow cytometry.

Main Results:

  • Successfully reduced CT120A transcripts by 50-70% and protein by approximately 80% in stable transfectants.
  • Observed a 30-40% decrease in cell growth rate and halved colony formation in soft agar.
  • Demonstrated significantly reduced tumorigenicity in vivo and increased sensitivity to UV-induced apoptosis.

Conclusions:

  • RNA interference-mediated down-regulation of CT120A effectively suppresses lung cancer cell growth.
  • CT120A represents a promising novel drug target for the development of lung cancer therapies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...